Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Orthopediatrics (KIDS) over the last 4 years, with Q3 2025 value amounting to $13.6 million.

  • Orthopediatrics' Other Non-Current Assets rose 3274.18% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 3274.18%. This contributed to the annual value of $10.4 million for FY2024, which is 25431.97% up from last year.
  • As of Q3 2025, Orthopediatrics' Other Non-Current Assets stood at $13.6 million, which was up 3274.18% from $13.9 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Other Non-Current Assets peaked at $13.9 million during Q2 2025, and registered a low of $614000.0 during Q2 2023.
  • Moreover, its 3-year median value for Other Non-Current Assets was $8.4 million (2024), whereas its average is $7.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 155152.98% in 2024, then surged by 3274.18% in 2025.
  • Over the past 3 years, Orthopediatrics' Other Non-Current Assets (Quarter) stood at $2.9 million in 2023, then skyrocketed by 254.32% to $10.4 million in 2024, then soared by 30.69% to $13.6 million in 2025.
  • Its last three reported values are $13.6 million in Q3 2025, $13.9 million for Q2 2025, and $12.8 million during Q1 2025.